Drug Profile
Gantacurium chloride
Alternative Names: AV 430A; Gantacurium; GW-280430Latest Information Update: 02 Feb 2011
Price :
$50
*
At a glance
- Originator Avera Pharmaceuticals
- Class Anaesthetics; Isoquinolines
- Mechanism of Action Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Anaesthesia
Most Recent Events
- 02 Feb 2011 No development reported - Phase-II for Anaesthesia in USA (IV-injection)
- 29 Jun 2006 Avera Pharmaceuticals has completed a phase II trial with gantacurium as an adjunct to general anaesthesia in the US
- 30 Nov 2005 Gantacurium is available for licensing worldwide (http://www.averapharm.com)